N-Acetyl Semax Amidate vs Semax: What the Modifications Change

Semax is already a modified peptide. N-Acetyl Semax Amidate is Semax modified twice more. Understanding what each modification does — and why peptide chemists keep reaching for these two specifically — explains the entire difference between the two products.

Start with what Semax already is

Semax (CAS 80714-61-0) is a heptapeptide: the ACTH(4-10) fragment Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues are lifted directly from adrenocorticotropic hormone. The trailing Pro-Gly-Pro is not — it was added deliberately.

Native ACTH(4-10) is degraded almost immediately in plasma. The Pro-Gly-Pro tail resists that degradation substantially, and the resulting peptide retains the neurotropic activity of the parent fragment while losing its hormonal activity. Semax was developed at the Institute of Molecular Genetics in Moscow and has been studied in Russian clinical research for stroke and cognitive indications for several decades.

The two additional modifications

N-terminal acetylation. A free N-terminus carries a positive charge and is the substrate that aminopeptidases recognise and cleave. Capping it with an acetyl group removes both the charge and the recognition site. This is one of the most common stabilising modifications in peptide chemistry precisely because it is cheap and effective.

C-terminal amidation. The opposite end carries a free carboxyl group with a negative charge. Converting it to an amide removes that charge and blocks carboxypeptidase cleavage. It also more closely mimics how many endogenous neuropeptides are naturally terminated — amidation is a real post-translational modification, not just a synthetic trick.

Together the two cap both ends of the molecule. The peptide backbone is unchanged; only the termini differ.

What that means in practice

The expected consequence is greater resistance to enzymatic degradation and therefore a longer functional window. This is a well-established principle in peptide chemistry generally.

What is worth being careful about is the leap from "more stable" to "more potent." Those are different claims. Terminal capping reliably improves stability; whether it improves activity depends on whether the termini were involved in receptor binding, which for this peptide is not firmly established in published work. Suppliers routinely present N-Acetyl Semax Amidate as simply a stronger Semax. The defensible statement is that it is a more enzymatically stable Semax.

The molecular formula for N-Acetyl Semax Amidate is C39H54N10O10S (PubChem CID 172638603). Unlike Semax it has no clean single CAS registry entry, which is itself a marker of how much newer it is.

Choosing between them

• Semax 10mg — the extensively studied form. If a protocol is replicating or extending published Semax work, this is the molecule that work used.

• N-Acetyl Semax Amidate 30mg — the stability-modified form, supplied at higher quantity per vial. Appropriate where enzymatic degradation is the limiting variable.

Both are also available as nasal sprays. Intranasal delivery is the route most of the Russian Semax literature used, which makes the atomiser format more faithful to the source research than it might first appear — a point worth noting, since Semax is one of the few research peptides where intranasal is the historically primary route rather than an alternative one.

Is N-Acetyl Semax Amidate stronger than Semax?

It is more resistant to enzymatic degradation, which is a claim about stability rather than potency. Whether the terminal modifications alter receptor activity is not firmly established in published work. Treat supplier claims of greater potency with appropriate scepticism.

What do the modifications actually do?

N-terminal acetylation blocks aminopeptidase cleavage; C-terminal amidation blocks carboxypeptidase cleavage. Both also neutralise a terminal charge. The peptide backbone between them is identical to Semax.

Why is the N-Acetyl version sold at 30mg when Semax is 10mg?

Quantity per vial is a supply decision, not a chemistry one. The larger fill reflects how the material is typically used and lowers cost per milligram.

Is the nasal spray the same material?

Yes — the same research-grade peptide, supplied in a 10 mL metered atomiser delivering 0.1 mL per actuation, shipped unmixed with its own sterile diluent for reconstitution on arrival.